91ֱ��

---

On this page:

• UK Research and Innovation (UKRI)
• Medical charity funders
  • Blood Cancer UK
  • British Heart Foundation
  • Cancer Research UK
  • Parkinson's UK
  • Versus Arthritis
  • Wellcome Trust
• National Institute for Health Research (NIHR)
• European Research Council (ERC)

---

UK Research and Innovation (UKRI)

See our UKRI open access policy guidance.

---

Medical charity funders (formerly COAF)

The Charity Open Access Fund (COAF) ended on October 1 2020, and its member charities (Wellcome Trust, Blood Cancer UK, Cancer Research UK, Parkinson’s UK and Versus Arthritis) now have separate open access policies.

Links to these policies and further information can be found below.

The Library now only manages open access block grants for the Wellcome Trust and British Heart Foundation. These grants may be used to pay APCs for gold open access with a CC BY license providing that funds are still available and certain conditions are met.

Email OAEnquiries@sheffield.ac.uk to confirm eligibility before committing to paid open access options offered by the publisher.

Blood Cancer UK

Blood Cancer UK’s open access policy can be found . They have not yet provided information about how they will support researchers with APC payments, but direct any enquiries to research@bloodcancer.org.uk.

British Heart Foundation

British Heart Foundation’s open access policy can be found .

The Library administers a grant on their behalf which can be used to support APC fees for the publication of peer reviewed, primary research articles and non-commissioned reviews funded wholly or in part by BHF, including any irrecoverable VAT on fees.

It will not support APCs associated with commissioned or invited review articles, conference proceedings, editorials, letters or commentaries and any other charges associated with the publication, such as page or colour charges.

Please get in touch with us at OAEnquiries@sheffield.ac.uk once your paper has been accepted to confirm eligibility.

Cancer Research UK

Cancer Research UK’s open access policy can be found . 91ֱ�� has not received an open access grant from CRUK this year.

CRUK advises that “researchers that receive funding from us but are not based at an institution which receives support from CRUK block grants may use any unspent grant funds to pay for APCs. Alternatively, until Jan 2022 authors can comply with our policy by self-archiving their publication in Europe PMC within 6 months, if the publisher permits.”

Direct any enquiries to grants.helpline@cancer.org.uk.

Parkinson's UK

Parkinson’s UK’s open access policy can be found . They expect grant applicants to include open access costs within their research grant applications.

Direct any enquiries to researchapplications@parkinsons.org.uk.

Versus Arthritis

Versus Arthritis’s open access policy can be found . Authors requiring support to publish articles open access should apply directly to the funder using their  tool.

Direct any enquiries to research@versusarthritis.org.

Wellcome Trust

See our Wellcome Trust open access policy guidance.

---

National Institute for Health Research (NIHR)

The National Institute for Health and Care Research (NIHR) have a which applies to peer reviewed journal articles (including non-commissioned reviews and conference papers accepted for final publication in a journal, conference proceeding with an ISSN number, or a publishing platform) submitted on or after 1st June 2022. More details about the scope of the policy can be found .

Under the new policy, the final Version of Record or Author Accepted Manuscript must be made available through PubMed Central and by the official final publication date, without an embargo period. The licence should be CC BY (or Open Government Licence when subject to Crown Copyright) unless you have applied for a CC BY-ND . Monographs, book chapters and edited collections are not in scope of the policy.

In order to help authors comply with this policy,  an ‘’ will be applied to NIHR awards issued from 1st June 2022. These funds can be used to pay “reasonable” open access charges for in-scope articles in fully open access or hybrid journals, and the Contractor is responsible for allocating this funding appropriately.  You can if needed. If funds are used to pay for open access, the publisher should agree to deposit the Version of Record into Europe PMC on behalf of the author.

NIHR open access funds will remain available for a period of two years after the contract completion date, and you can . Open access funds cannot be used to cover page or colour charges, or open access charges for publications not in-scope of the policy.

91ֱ�� has a growing number of transitional agreements with publishers, which can be found on the following page. Articles published with a CC BY licence under these agreements will be compliant with NIHR, and will not require the use of additional funds.

You can also comply with the policy by depositing the Author Accepted Manuscript into Europe PMC, where it will be made available without an embargo period. This route does not require use of funds. In order to enable you to do this, articles submitted to hybrid/subscription journals should include the following statement:

"For the purpose of Open Access, the author has applied a Creative Commons Attribution (CC BY) licence* to any Author Accepted Manuscript version arising".

*where permitted by NIHR, ‘Open Government Licence or ‘Creative Commons Attribution No-derivatives (CC BY-ND) licence may be stated instead

Authors taking this route should be careful not to sign a copyright transfer agreement or contract conflicting with the statement (eg. agreeing to an embargo or a more restrictive licence).

In-scope research articles should also include a data-sharing statement describing how the underpinning research data can be accessed, and of NIHR, including unique award identifier. 

---

European Research Council (ERC)

Horizon 2020 grant-holders (2014-2020) must ensure open access to all peer-reviewed publications resulting from funded research. Papers published during the project lifetime must be made open access either on the publisher's website or via a repository no later than 6 months (STEM) and 12 months (AHSS) from the date of publication. There is more flexibility for post-grant publications, which must be made open access via a repository but with no restrictions on embargo length.

Horizon Europe grant-holders (2021-2027) must ensure immediate open access with a CC BY licence to all peer-reviewed publications (including monographs*) resulting from funded research.

Publications can be made open access with a CC BY licence on the publisher's website or by depositing into a repository such as White Rose Research Online (WRRO). If you are publishing in a fully open access journal, publishing platform or are publishing a fully open access monograph, open access charges are eligible costs if incurred during the lifetime of your project. If you are publishing in a hybrid journal or are publishing a monograph where parts are not open access then these charges are not eligible costs. 

If you are unable to publish open access immediately on the publisher's website, you must make the Author Accepted Manuscript version available through a repository on publication and with a CC BY licence. Please note that most publisher policies do not permit this without you taking the additional steps outlined in the University of 91ֱ�� Research Publications and Copyright Policy (applicable to articles submitted after 1st January 2023). Complying with our policy will help you retain the rights necessary to comply with your Horizon Europe requirements.

Further details are available on the . 

*Longform publications such as monographs can also be published under -NC or -ND Creative Commons licenses. 

For further information, contact OAEnquiries@sheffield.ac.uk.